Schedule 13G ownership disclosure
OKYO PHARMA LTD
Common · CUSIP: G6724L116
Event date: 2025-05-23
- Filing-level shares
- 2,301,300.00
- Percent of class
- 6.8%
- Chernett Jorey
Shares: 2,301,300.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137439-25-000528
- Form type
- SCHEDULE 13G
- Filer
- Chernett Jorey
- CIK
- CIK 2042077
- Filed
- May 27, 2025
- Reporting period
- May 23, 2025
- Description
- Schedule 13G beneficial ownership